drugset / Trial / NCT02138552

Dose Finding Study to Assess Octenidine Mouthwash Concentrations in Comparison to Placebo

NCT02138552

Phase 2 Completed 90 enrolled Schülke & Mayr GmbH
RandomizedCrossoverQuadruple-blindTreatment

Summary

The objective of this clinical trial is to identify the most efficacious octenidine dihydrochloride concentration regarding bacterial count reduction in comparison to a placebo in the oral cavity.

Timeline

Start
2013-10
Primary completion
2014-04
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Octenidine Small molecule 0.1 % Other
Comparator Octenidine Small molecule 0.15 % Other
Comparator Octenidine Small molecule 0.2 % Other

Indications